GSR Ventures

GSR Ventures is a multi-stage venture firm with offices in the US and China, operating with a thesis focused on early-stage and growth investing in technology businesses, including substantive healthcare and digital health exposure across both markets. The gsrventures.com website confirms an established cross-border platform with portfolio depth in healthcare AI, telehealth, digital therapeutics, and healthcare technology. For healthcare AI founders, GSR is a credible match for businesses with strong technical defensibility and either US or cross-border ambition, particularly digital health, AI-driven diagnostics, telehealth platforms, and healthcare-flavored B2B SaaS. Plausible check sizes run 1M to 10M at Series A and B, with selective follow-on. The firm leads or co-leads. Founders building healthcare AI with software economics and clear category positioning should approach. Founders building deep biotech requiring substantial pre-clinical investment, or regulated medical devices with long FDA timelines, should evaluate fit carefully; GSR’s strength is in software-economics businesses. Entry path is warm introduction through portfolio founders, US or China-based digital health operator networks, or other healthcare investors in their syndicate networks. The firm reads inbound and responds to substantive pitches. Diligence will be sharp on B2B SaaS or consumer metrics with attention to healthcare market dynamics, payer reimbursement, and competitive positioning. The value-add includes cross-border network access (a real differentiator for founders considering Asian expansion or partnerships), healthcare market expertise, and follow-on capacity from a multi-stage platform. Bring substantive ARR or user metrics. Realistic expectations: this is institutional venture capital for healthcare AI businesses with proven traction and clear scaling potential.